Cargando…
Biomarkers in critical illness: have we made progress?
Biomarkers have emerged as exemplary key players in translational medicine. Many have been assessed for timely recognition, early treatment, and adequate follow-up for a variety of pathologies. Biomarker sensitivity has improved considerably over the last years but specificity remains poor, in parti...
Autores principales: | Honore, Patrick M, Jacobs, Rita, Hendrickx, Inne, De Waele, Elisabeth, Van Gorp, Viola, Joannes-Boyau, Olivier, De Regt, Jouke, Boer, Willem, Spapen, Herbert D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074734/ https://www.ncbi.nlm.nih.gov/pubmed/27799811 http://dx.doi.org/10.2147/IJNRD.S113219 |
Ejemplares similares
-
A fresh look into the pathophysiology of ischemia-induced complications in patients with chronic kidney disease undergoing hemodialysis
por: Honore, Patrick M, et al.
Publicado: (2015) -
Critical care nephrology: could it be a model of multidisciplinarity in ICU nowadays for other sub-specialities – the jury is out
por: Honoré, Patrick M, et al.
Publicado: (2014) -
Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: we still need to straighten out the dose!
por: Honore, Patrick M., et al.
Publicado: (2015) -
Acute respiratory muscle weakness and apnea in a critically ill patient induced by colistin neurotoxicity: key potential role of hemoadsorption elimination during continuous venovenous hemofiltration
por: Honore, Patrick M, et al.
Publicado: (2013) -
Biomarkers for early diagnosis of AKI in the ICU: ready for prime time use at the bedside?
por: Honore, Patrick M, et al.
Publicado: (2012)